Journal of Drugs in Dermatology

View more issues:

Articles in March-April, 2005 issue of Journal of Drugs in Dermatology

• Tretinoin treatment before carbon dioxide laser resurfacing: a clinical and biochemical analysis
• Photodynamic therapy in treating patients with skin cancer
• Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study
• Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel as monotherapy and in combination
  by Joseph B. Bikowski
• Acute generalized lichen planus treated with weekly betamethasone 5-mg oral mini-pulse therapy
  by Nawaf Al-Mutairi
• Focus on: biologics that affect therapeutic agents in dermatology
  by Yamini V. Saripalli
• Comparison of telavancin and vancomycin for complicated skin and skin structure infections with a focus on methicillin-resistant staphylococcus aureus
• Review of cyclosporine immunosuppressive safety data in dermatology patients after two decades of use
  by Shahrad M. Behnam
• Oral alitretinoin therapy for chronic hand dermatitis in patients refractory to standard therapy
• Photodynamic therapy in treating patients with skin cancer
• Onercept in the treatment and re-treatment of subjects with moderate to severe plaque psoriasis
• Enhanced full-face skin rejuvenation using synchronous intense pulsed optical and conducted bipolar radiofrequency energy : introducing selective radiophotothermolysis
  by Neil S. Sadick
• Drugs used in the treatment of pediculosis
  by Dirk M. Elston
• Scrotal ulceration as a consequence of all-trans-retinoic acid for the treatment of acute promyelocytic leukemia
  by Soheil Simzar
• First-time generic formulations approved for Ultravate®, Elocon®, Locoid®, and Loprox®
• Etanercept in psoriasis pediatrics
• Remicade® associated with risks of hepatotoxicity and pneumonia
• Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin
• Barrier Therapeutics, Inc., announces Phase III results for Sebazole gel
• Bioengineered skin and wound healing
• Topical imiquimod compared with surgery in treating patients with basal cell skin cancer
• Tazarotene cream versus adapalene cream in the treatment of facial acne vulgaris: a multicenter, double-blind, randomized, parallel-group study
  by A. Shalita
• Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine
• Linezolid in the treatment of complicated skin and soft tissue due to methicillin-resistant staphylococcus aureus
• Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy
  by Dore J. Gilbert
• Ten commandments for minimal pain during administration of local anesthetics
  by Isaac Zilinsky
• RFID surgical marker minimizes errors of patient, site, and procedure
• Infliximab to treat dermatomyositis and polymyositis
• Therapy of hypereosinophilic syndrome, polycythemia vera, atypical CML or CMML with PDGF-R fusion genes, or mastocytosis with Gleevec
• Dioxin toxicity and chloracne in the Ukraine
  by J. Barton Sterling
• Tazarotene cream in combination with betamethasone valerate foam for plaque-type psoriasis
  by Sunil S. Dhawan
• Voriconazole for Candida Blood, deep tissue, and other infections
• Phase II trial using infliximab in subjects with giant cell arteritis
• Nonmelanomas: 25 years of change
  by Rex A. Amonette
• Self-anchoring suture for nonsurgical mid-face lifts and wound closure of dermal tissue
• Study the effects of CD25 and low dose cyclosporin in the treatment of active psoriasis vulgaris
• Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia
  by E. Ladoyanni
• Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial
• New TB blood test more accurate than tuberculin skin test
• Celecoxib in preventing skin cancer
• Skin bleaching products in Africa
  by Melanie Miyanji de Souza
• Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus
  by Naomi Creel
• A letter from the Editor-in-Chief
  by Perry Robbins
• Co-existence of lichen planus and sarcoidosis
  by M. Ali
• GentleWaves LED gains FDA approval
• Palifermin reduces incidence and duration of severe mucositis
• Study the use of humanized CD25 in preventing the relapse of psoriasis vulgaris
• ZD1839 for recurrent or metastatic squamous cell carcinoma of the skin
• Orlando Dermatology and Cosmetic Conference
  by Eric Huang
• Prescribing patterns for topical retinoids within NAMCS data
  by Rajesh Balkrishnan
• Colchicine for dermatologic diseases
  by Roberta Bibas
• Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin
• Bevacizumab to treat Kaposi's sarcoma in HIV-positive and HIV-negative patients